Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zulresso in Postpartum Psychosis
NCT05314153Phase 1Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Feb 2022
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of brexanolone in postpartum psychosis (PPP), sponsored by University of North Carolina at Chapel Hill. Primary endpoints: Positive and Negative Syndrome Scale at Day 7 and Young Mania Rating Scale at Day 7. Started Feb 2022; status: completed.
02
Drugs
brexanolone
03
Conditions
postpartum psychosis (PPP)
Beyond the preview
Go deeper on NCT05314153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05314153.